Join companies like...
4D pharma plc - Abbvie - Arbor Pharmaceuticals - Artax Biopharma - Asymchem - Atomwise - Beigene - Biognosys AG - BioValley France - Boehringer Ingelheim - Cerebral Therapeutics, Inc. - Corbus Pharmaceuticals - CSL Behring - Daiichi Sankyo - Elanco - EMD Serono - ExactCure - Exopharm - Fortress Biotech - Galapagos BV - Horizon Therapeutics - Johnson & Johnson Innovation - Kaken Pharmaceutical - MPM Capital - MSD - Novotech - Oxford BioMedica - Servier - Sitryx Therapeutics Ltd - UCB
Companies profile
Attendees profile
Asset phase
“ALLERO is coming to Immunology Virtual Partnering to present our novel SOMIT platform technology for antigen specific immunotherapy of autoimmune and allergic disorders. The targeted one-on-one meetings specifically focused on Immunology will allow us to identify the best partners for this project.”
Why participate?
Find potential R&D collaborations or assets available for in-licensing/acquisition
Identify partners with research solutions such as high throughput screening tools, clinical research capacity, or animal models
Secure funding from new investors or find licensing partners for your portfolio
Discover new diagnostics, biomarkers, adjuvants, carrier systems or technologies
Who will attend?
The event is open to any organization that provides assets, products, knowledge or technologies that can help advance the immunology pipelines.
The deployment of successful solutions requires the engagement and implication of multiple stakeholders such as:
Business development, licencing, and scouting executives from the biopharma industry
Biotechs focused on immunology
Early stage researchers from academia, incubators, or research foundations
Companies focusing on immunology related diagnostics or biological markers
Tech transfer offices
Companies providing research tools, models or services needed for immunology R&D
